379 related articles for article (PubMed ID: 19407487)
41. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
[TBL] [Abstract][Full Text] [Related]
42. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
[TBL] [Abstract][Full Text] [Related]
43. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins.
Samari HR; Møller MT; Holden L; Asmyhr T; Seglen PO
Biochem J; 2005 Mar; 386(Pt 2):237-44. PubMed ID: 15461583
[TBL] [Abstract][Full Text] [Related]
44. Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts.
Hattori Y; Akimoto K; Nishikimi T; Matsuoka H; Kasai K
Hypertension; 2006 Feb; 47(2):265-70. PubMed ID: 16380538
[TBL] [Abstract][Full Text] [Related]
45. Central role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogenesis in L6 myocytes.
McConell GK; Ng GP; Phillips M; Ruan Z; Macaulay SL; Wadley GD
J Appl Physiol (1985); 2010 Mar; 108(3):589-95. PubMed ID: 20044477
[TBL] [Abstract][Full Text] [Related]
46. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
[TBL] [Abstract][Full Text] [Related]
48. Activation of 5' adenosine monophosphate-activated protein kinase blocks cumulus cell expansion through inhibition of protein synthesis during in vitro maturation in Swine.
Santiquet N; Sasseville M; Laforest M; Guillemette C; Gilchrist RB; Richard FJ
Biol Reprod; 2014 Aug; 91(2):51. PubMed ID: 25031357
[TBL] [Abstract][Full Text] [Related]
49. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
50. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
Goirand F; Solar M; Athea Y; Viollet B; Mateo P; Fortin D; Leclerc J; Hoerter J; Ventura-Clapier R; Garnier A
J Physiol; 2007 Jun; 581(Pt 3):1163-71. PubMed ID: 17446219
[TBL] [Abstract][Full Text] [Related]
51. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
52. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.
Wong AK; Howie J; Petrie JR; Lang CC
Clin Sci (Lond); 2009 Apr; 116(8):607-20. PubMed ID: 19275766
[TBL] [Abstract][Full Text] [Related]
53. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses.
Rao E; Zhang Y; Li Q; Hao J; Egilmez NK; Suttles J; Li B
Oncotarget; 2016 Jun; 7(23):33783-95. PubMed ID: 27177226
[TBL] [Abstract][Full Text] [Related]
54. Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio.
Wang Y; Wang B; Guerram M; Sun L; Shi W; Tian C; Zhu X; Jiang Z; Zhang L
Oncotarget; 2015 Oct; 6(30):29497-512. PubMed ID: 26470595
[TBL] [Abstract][Full Text] [Related]
55. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
Petti C; Vegetti C; Molla A; Bersani I; Cleris L; Mustard KJ; Formelli F; Hardie GD; Sensi M; Anichini A
Melanoma Res; 2012 Oct; 22(5):341-50. PubMed ID: 22588166
[TBL] [Abstract][Full Text] [Related]
56. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
Guo D; Hildebrandt IJ; Prins RM; Soto H; Mazzotta MM; Dang J; Czernin J; Shyy JY; Watson AD; Phelps M; Radu CG; Cloughesy TF; Mischel PS
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12932-7. PubMed ID: 19625624
[TBL] [Abstract][Full Text] [Related]
57. AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway.
Morishita M; Kawamoto T; Hara H; Onishi Y; Ueha T; Minoda M; Katayama E; Takemori T; Fukase N; Kurosaka M; Kuroda R; Akisue T
Int J Oncol; 2017 Jan; 50(1):23-30. PubMed ID: 27878239
[TBL] [Abstract][Full Text] [Related]
58. Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells.
Willows R; Sanders MJ; Xiao B; Patel BR; Martin SR; Read J; Wilson JR; Hubbard J; Gamblin SJ; Carling D
Biochem J; 2017 Aug; 474(17):3059-3073. PubMed ID: 28694351
[TBL] [Abstract][Full Text] [Related]
59. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
Liu S; Tang Y; Yan M; Jiang W
Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
[TBL] [Abstract][Full Text] [Related]
60. Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells.
Kimura T; Tomura H; Sato K; Ito M; Matsuoka I; Im DS; Kuwabara A; Mogi C; Itoh H; Kurose H; Murakami M; Okajima F
J Biol Chem; 2010 Feb; 285(7):4387-97. PubMed ID: 20018878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
